238749-19-4

Basic information

• Product Name: Methyl 2-cyano-4-(3,4-dichlorobenzyl)furo[3,2-b ]pyrrole-5-carboxylate
• Synonyms: Methyl 2-cyano-4-(3,4-dichlorobenzyl)furo[3,2-b ]pyrrole-5-carboxylate
• CAS NO: 238749-19-4
• Molecular Weight: 349.173
• Mol File: 238749-19-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Methyl 2-cyano-4-(3,4-dichlorobenzyl)furo[3,2-b ]pyrrole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-cyano-4-(3,4-dichlorobenzyl)furo[3,2-b ]pyrrole-5-carboxylate(238749-19-4)
• EPA Substance Registry System: Methyl 2-cyano-4-(3,4-dichlorobenzyl)furo[3,2-b ]pyrrole-5-carboxylate(238749-19-4)

Safety Data

• Hazardous Substances Data: 238749-19-4(Hazardous Substances Data)

Upstream product

• 238749-16-1 Methyl 4-(3,4-dichlorobenzyl)-2-formylfuro[3,2-b ]pyrrole-5-carboxylate 
• 5470-11-1 hydroxylamine hydrochloride 

Relevant articles and documents

Bicyclic pyrrole derivatives as MCP-1 inhibitors

A pharmaceutical composition comprising a compound of formula (I): or a pharmaceutically acceptable salt, ester or amide thereof, which is an inhibitor of monocyte chemoattractant protein-1 and wherein A and B together form an optionally substituted 5-member aromatic ring which includes at least one heteroatom; R1is an optionally substituted aryl or heteroaryl ring; R2is selected from a range of organic groups including carboxy, and R3is hydrogen, or a range of organic groups; in combination with a pharmaceutically acceptable carrier. Certain compounds of formula (I) are novel and these form a further aspect of the invention.